Estimates based on drug properties and standard treatment parameters.
3.9 mL/min
Poorly Dialyzable
Minimal removal expected. Half-life: 3 days (acute). No supplementation needed. Despite long half-life, clearance is low due to other factors.
Data Used:
✅
protein_binding, molar_mass, mw_factor, vd, vd_factor, half_life
Free fraction:
0.06
Mw factor:
1
Vd factor:
0.2
Hl factor:
1.2
Half life:
3 days (acute)
Half life category:
Extended (> 72h)
1.2 mL/min
Low PD Clearance
Minimal removal expected. No supplementation needed. Half-life: 3 days (acute).
Data Used:
✅
protein_binding, molar_mass, half_life
Free fraction:
0.06
Half life:
3 days (acute)
Half life category:
Extended (> 72h)
Moderate Risk
This drug may be removed by TPE. Long half-life may increase significance. Consider monitoring.
Data Used:
✅
protein_binding, vd, half_life
Half life:
3 days (acute)
Half life category:
Extended (> 72h)
Low Effectiveness
Poor candidate for hemoperfusion. Drug is distributed in tissues.
Data Used:
✅
vd, half_life
Half life:
3 days (acute)
Half life category:
Extended (> 72h)
